Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,971 | -25,788 | -21,397 | -11,716 | -7,839 |
| Depreciation Amortization | 266 | 252 | 235 | 476 | 934 |
| Accounts receivable | -1,405 | 2,391 | -1,406 | -1,114 | 3,001 |
| Accounts payable and accrued liabilities | 1,854 | 2,440 | -749 | 2,165 | -364 |
| Other Working Capital | 1,288 | 4,846 | -943 | 2,842 | 3,067 |
| Other Operating Activity | 3,494 | -159 | 5,727 | 3,716 | -2,232 |
| Operating Cash Flow | $-28,474 | $-16,018 | $-18,533 | $-3,631 | $-3,433 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -147 | -171 | -27 | -10 |
| Investing Cash Flow | $-4 | $-147 | $-171 | $-27 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 8,942 | 5,372 |
| Debt Repayment | N/A | N/A | N/A | N/A | -4 |
| Common Stock Issued | 24,432 | 5,332 | 6,942 | 44,527 | 47 |
| Other Financing Activity | -867 | -811 | -1,396 | -268 | 350 |
| Financing Cash Flow | $23,565 | $4,521 | $5,546 | $53,201 | $5,765 |
| Exchange Rate Effect | N/A | 4 | -1 | -11 | -23 |
| Beginning Cash Position | 29,922 | 41,562 | 54,721 | 5,189 | 2,890 |
| End Cash Position | 25,009 | 29,922 | 41,562 | 54,721 | 5,189 |
| Net Cash Flow | $-4,913 | $-11,640 | $-13,159 | $49,532 | $2,299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,474 | -16,018 | -18,533 | -3,631 | -3,433 |
| Capital Expenditure | -4 | -147 | -171 | -27 | -10 |
| Free Cash Flow | -28,478 | -16,165 | -18,704 | -3,658 | -3,443 |